Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 funding notice text was removed.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide notice about funding lapse and operating status was added, and the footer now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.4%

- Check69 days agoChange DetectedThe Record History page now includes a glossary option and color-coded additions and deletions with revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedRevision history shows a new entry for v3.3.4 and removal of v3.3.3, updating the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.